BioStock: Status update from CombiGene's CEO

With the first quarter of the year concluded, CombiGene's CEO Jan Nilsson visited BioStock's studio for a status update on the gene therapy company's project. Nilsson not only talks about the pain project COZY and the epilepsy candidate CG01, but also about the company's financial status.

Watch the interview with Jan Nilsson at biostock.se:

https://www.biostock.se/en/2023/05/status-update-from-combigenes-ceo/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/